Bristol Myers Squibb and Bain Capital Create New Company Dedicated to Developing Innovative Immunology Therapies that Address the Unmet Medical Needs of Patients - Bristol Myers Squibb

PRINCETON, N.J. & BOSTON--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY, BMS) and Bain Capital today announced the creation of a new independent biopharmaceutical company (NewCo) focused on…